Skip to main content
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
14.01
-0.10 (-0.71%)
At close: Nov 15, 2024, 4:00 PM
13.79
-0.22 (-1.57%)
After-hours: Nov 15, 2024, 5:08 PM EST

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $2.07M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $2.57M, up 8,460.00% year-over-year. In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K, down -97.72%.

Revenue (ttm)
$2.57M
Revenue Growth
+8,460.00%
P/S Ratio
n/a
Revenue / Employee
$98,769
Employees
26
Market Cap
1.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M-12.33M-69.13%
Dec 31, 202017.84M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SPRY News

More News